Evan Katz

462 total citations
3 papers, 201 citations indexed

About

Evan Katz is a scholar working on Organic Chemistry, Epidemiology and Physiology. According to data from OpenAlex, Evan Katz has authored 3 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Organic Chemistry, 2 papers in Epidemiology and 2 papers in Physiology. Recurrent topics in Evan Katz's work include Lysosomal Storage Disorders Research (2 papers), Trypanosoma species research and implications (2 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Evan Katz is often cited by papers focused on Lysosomal Storage Disorders Research (2 papers), Trypanosoma species research and implications (2 papers) and Carbohydrate Chemistry and Synthesis (2 papers). Evan Katz collaborates with scholars based in United States. Evan Katz's co-authors include Kenneth J. Valenzano, John J. Flanagan, David J. Lockhart, C.W. Pine, Adriane Schilling, Benjamin Elias, Hui‐Hwa Chang, Xi Wu, Brandon A. Wustman and Robert J. Desnick and has published in prestigious journals such as Human Mutation, Molecular Genetics and Metabolism and Journal of Inherited Metabolic Disease.

In The Last Decade

Evan Katz

2 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan Katz United States	2	170	91	86	70	62	3	201
Maria Cecilia Della Valle United States	5	167 1.0×	72 0.8×	49 0.6×	87 1.2×	86 1.4×	5	235
Jeff Castelli United States	5	101 0.6×	49 0.5×	46 0.5×	27 0.4×	28 0.5×	16	135
Nada Al Eisa United Kingdom	3	150 0.9×	45 0.5×	46 0.5×	19 0.3×	37 0.6×	3	175
Khan Nedd United States	5	138 0.8×	69 0.8×	50 0.6×	28 0.4×	35 0.6×	6	150
Elsa Ávila Arreguin Mexico	6	397 2.3×	189 2.1×	184 2.1×	163 2.3×	137 2.2×	15	418
María José Coll Spain	3	114 0.7×	37 0.4×	18 0.2×	20 0.3×	37 0.6×	4	133
Gustavo Charria-Ortiz United States	3	154 0.9×	48 0.5×	38 0.4×	54 0.8×	23 0.4×	4	187
Cristina Fraga Portugal	3	100 0.6×	41 0.5×	35 0.4×	30 0.4×	34 0.5×	6	128
Ivan Doykov United Kingdom	6	62 0.4×	24 0.3×	16 0.2×	26 0.4×	34 0.5×	10	92
Marcelo Kerstenetzky Brazil	4	142 0.8×	68 0.7×	62 0.7×	68 1.0×	32 0.5×	5	158

Countries citing papers authored by Evan Katz

Since Specialization

Citations

This map shows the geographic impact of Evan Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Katz more than expected).

Fields of papers citing papers by Evan Katz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Katz. The network helps show where Evan Katz may publish in the future.

Co-authorship network of co-authors of Evan Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Katz. A scholar is included among the top collaborators of Evan Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Katz. Evan Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Wu, Xiaoyang, Evan Katz, Maria Cecilia Della Valle, et al.. (2011). A pharmacogenetic approach to identify mutant forms of α‐galactosidase a that respond to a pharmacological chaperone for Fabry disease. Human Mutation. 32(8). 965–977. 65 indexed citations

2.

Elias, Benjamin, John J. Flanagan, Adriane Schilling, et al.. (2009). The pharmacological chaperone 1‐deoxygalactonojirimycin increases α‐galactosidase A levels in Fabry patient cell lines. Journal of Inherited Metabolic Disease. 32(3). 424–440. 135 indexed citations

3.

Wu, Xiaoyang, Evan Katz, Hui‐Hwa Chang, et al.. (2008). 113. Identification of Fabry disease-causing mutations that are responsive to the pharmacological chaperone AT1001. Molecular Genetics and Metabolism. 93(2). 43–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact